Psychiatry short Flashcards

A SUMMARY OF MAIN CONDITIONS IN PSYCHIATRY

1
Q

Lewy-body dementia

A

Dementia caused by accumulation of misfolded alpha-synuclein protein in the brain.

Clinical features: fluctuating cognition and concentration, visual hallucinations (usually small animals), parkinsonism.

1st line: AChE (Acetylcholinesterase) inhibitor: donepezil

Caution with antipsychotics as exacerbates parkinsonism

Non-pharmacological interventions: cognitive stimulation, physical therapy, and occupational therapy.

Supportive care: progressive disease so palliative and end-of-life care considerations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alzheimer’s disease

A

Progressive neurogenerative disorder, apolipoprotein E gene mutation

Accumulation of amyloid plaques and tau tangles in the brain leads to cognitive decline.

4As:

  • Amnesia - recent memory lost first
  • Aphasia - word-finding difficulties and disjointed/muddled speech
  • Agnosia - difficulties with recognition
  • Apraxia - difficulties with skilled tasks despite normal motor function

Dx: detailed history and neuro exam, cognitive screening e.g. 10-point cognitive screen (10-CS), GPCog, 6CIT

Mx: education and support for patient and family, memory clinic, cognitive stimulation therapy

Medical: acetylcholinesterase inhibitors e.g. donepezil (duh-neh-puh-zil) or galantamine and NMDA receptor antagonist e.g. memantine (rhymes with clementine) if more severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vascular dementia

A

Cognitive impairment due to cerebrovascular disease - stepwise decline

Clinical features:

  • Cerebrovascular risk factors e.g. smoking, high BMI, stroke
  • Memory disturbances
  • Sensory or motor symptoms

Gait/speech/emotional disturbance

Dx: detailed history and examination, cognitive screening, exclude medication or organic causes e.g. B12 deficiency, MRI to visualise vascular changes

Mx: optimise management of co-morbidities, cognitive stimulation therapy, and medication e.g. donepezil or memantine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Frontotemporal dementia

A

Neurodegenerative disorder mainly affecting the frontal and temporal lobes of the brain.

Younger onset 60 - 70

  • Personality changes: apathy, disinhibition
  • Language impairment: word-finding and aphasia
  • Cognitive decline
  • Motor symptoms: muscle weakness, dysarthria

Associated with ALS

Mx: Counselling, behavioural modification, SSRI, speech and language, physio, OT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Differentiating LBD and PD

A
  • If cognitive and motor symptoms occur within 1 year of each other = LBD
  • If motor symptoms develops and cognitive symptoms occur > 1 year after = PD

Mx: memory clinic, cognitive stimulation therapy, physiotherapy

Medical Mx: acetylcholinesterase inhibitors e.g. donepezil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What blood tests are carried out in the investigations for dementia?

A

Confusion screen in primary care

FBC, U+E, LFTs, CRP/ESR, calcium, TFTs, B12, folate, syphilis, HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Schizophrenia

A

Positive symptoms:

  • Auditory hallucinations (narration of patient’s actions, hearing own thoughts out loud, third person)
  • Broadcasting of thought - others can hear thoughts -
  • Thought insertion + withdrawal
  • Control issues (somatic passivity (external entity controlling sensations and actions)
  • Delusions - persecutory and perceptions (i.e. ordinary perception: the cat meowed, delusion: so I knew I would meeting the aliens today)
  • Idea of reference (false belief that unconnected events or details in the world relate to them)

Negative symptoms (4As): affective flattening (minimal emotional reactions, alogia, anhedonia, avolition

Dx:

Rule out organic causes first always

  • ICD11 - symptoms present for at least one month, causing significant distress
  • DSM5 - at least 6 months, with one month of active-phase symptoms (at least one ABCD)

Mx: 2nd gen antipsychotics e.g. olanzapine, risperidone, clozapine if resistant (monitor for agranulocytosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bipolar affective disorder

A

Bipolar type 1: one or more manic episodes at least 1 week, and one or more depressive episodes

Bipolar type 2: episodes of MDD and hypomania (at least 4 consecutive days)

Mania episodes = persistently elevated, expansive or irritable mood, hypomanic symptoms less severe

Mx: Rule out organic causes first always! Otherwise clinical Dx

  • Stop SSRI if recently started “manic switch”
  • Acute: 2nd gen antipsychotics if psychosis - IM if agitated, PO if not
  • Maintenance with lithium and psychotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anorexia nervosa

A
  • BMI < 17.5kg/m2
  • Severe dietary restriction
  • Weight and shape preoccupation
  • Distorted body image
  • Restrictive or bulimic subtype

Blood tests:
- Low K, Ca and Mg
- Metabolic alkalosis if bulimic subtype
- Low FSH, LH, testosterone and oestrogen
- High cortisol and growth factor
- Normal T4, low T3

Mx:

  • CBT for eating disorder
  • 1st line for under 18s = AN-focused family therapy
  • SSRI to help co-existing depression/anxiety
  • Sectioning under MHA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bulimia nervosa

A
  • Patients often have normal BMI
  • At least 3 months of cycles binge-eating then inappropriate compensatory behaviours to prevent weight gain e.g. vomiting, laxatives, fasting, excessive exercise
  • Dental erosion, parotid gland swelling, Russell’s sign (calluses on knuckles from scraping teeth), amenorrhoea

Mx:

  • Adults: 1st line: BN focused guided self-help, and specialist referral
  • Children: BN-focused family therapy +/- fluoxetine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Difference between anorexia vs bulimia - EXAM FODDER

A

BMI is a key distinguishing feature

AN is defined by BMI < 17.5kg/m2

Patients with BN have normal BMI or BMI within the “healthy range”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Emotionally unstable personality disorder (EUPD)

A

4 domains:

  • Unstable self-image
  • Difficulties maintaining relationships
  • Impulsivity
  • Recurrent suicidal or self-harm behaviour

Mx: Dialectical behavioural therapy (DBT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Depression

A

Core symptoms over 2 weeks:

  • Low mood
  • Anhedonia (a lack of pleasure or interest in activities)

Other symptoms: change in sleep, >5% weight gain or loss, excessive guilt, hopelessness, thought of suicide and self-harm

Dx: FBC, TFT, U_E, LFT, Patient Health Questionnaire (PHQ-9)

PHQ-9:
- 5 - 9 = mild
- 10 - 14 moderate
- 15 - 19 moderately severe
- 20 - 27 severe

Mx:
Lifestyle e.g. diet, exercise, stress, alcohol

Mild - low-intensity psychotherapy e.g. self-guided help, online CBT

Moderate to severe:

  • 1st line - high-intensity CBT + SSRI

Severe depression with poor oral intake: electroconvulsive therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Delirium tremens

A

Severe alcohol withdrawal characterised by acute confusion, hallucination (visual/tactile), sweating, hypertension, seizures

Occurs around 72 hours after stopping drinking alcohol

Mx:
- Acute: 1st line is oral lorazepam

  • Maintenance: chlordiazepoxide, eventually tapered, adequate hydration, Pabrinex, referral to local drug and alcohol liasion team
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define the Mental Health Act

A

The Mental Health Act 1983 as amended by the Mental Health Act 2007 sets out a legal framework for the care and treatment of individuals with mental health disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sections under MHA

A
  • Section 135: allows police to enter a person’s home and remove them
  • Section 136: allows police to remove a person with suspected/confirmed mental condition from a public place to place of safety e.g. hospital
  • Section 5(2) - doctor’s holding powers, detains a patient for 72 hours while waiting for mental health assessment - change to section 2 or remove
  • Section 2 - 28 days assessment order - compulsory detention for assessment, can be extended to section 3
  • Section 3 - up to 6 months treatment order, compulsory detention for diagnosis and treatment for a mental health disorder
17
Q

Mania

A
  • Increased energy, reduced need for sleep, pressured speech, elevated/irritated mood, impulsivity, potentially psychotic symptoms
  • Impairs daily, occupational and social functioning.

Hypomania does not impair functioning and no psychosis

18
Q

Antipsychotics safe in breastfeeding mothers

A

Olanzapine and quetiapine for postpartum psychosis

19
Q

Lithium therapeutic window

A

Narrow therapeutic window: 0.4 - 1.0mmol

  • Increased thirst, polyuria, weight gain, blurred vision, hypothyroidism

Toxic levels > 1.5mmol/L

  • Nausea + vomiting, coarse tremors, muscle weakness, ataxia

Dangerously toxic levels > 2mmol/L

  • Nystagmus, dysarthria, reduced consciousness, hypotension, convulsions, coma
20
Q

Side effects of antipsychotics

A

Extra-pyramidal side effects

  • Tardive dyskinesia - uncontrollable repetitive movements often affecting face and jaw
  • Akathisia - inability to stay still (psychomotor restlessness)
  • Acute dystonia - involuntary muscle spasms
  • Parkinsonism - tremors, rigidity and bradykinesia

2nd gen have increased metabolic side-effects : e.g. weight gain, hyperglycaemia, diabetes, hypertension

Procyclidine for EPSEs

21
Q

Generalised anxiety disorder (GAD)

A

At least 6 months of excessive, uncontrollable worry that causes significant distress and impairment

Associated symptoms: restlessness, palpitations, difficulties concentrating, fatigue, muscle tension

Dx: screening = GAD-7 questionnaire

Mild: 5 - 9
Moderate: 10 - 14
Severe: 15 - 21

Mx: first line: low-intensity psychological interventions e.g. individual self-help online, guided self-help, group CBT

Second line: CBT and/or SSRI e.g. sertraline

22
Q

Obsessive-compulsive disorder

A

A mental health disorder characterised by obsessions (unwanted thoughts/images) and/ or compulsions to alleviate the distress. The compulsions consume significant time (>1hr a day) and/ or cause significant distress.

Mx:

  • Mild - low-intensity CBT
  • Moderate - offer intensive CBT, e.g. exposure and response prevention therapy (ERP) or SSRI
  • Severe: offer high-intensity CBT and SSRI
23
Q

Thought disorder descriptions

A
  • Thought broadcasting - the person believes that everyone can hear their thoughts
  • Thought withdrawal - belief that thoughts are being removed by an external force
  • Thought blocking - the person suddenly stops their thought process and cannot continue
  • Derailment - conversation moves randomly from topic to topic
24
Q

Delirium

A

Fluctuating, reversible disturbance in attention and cognition, acute confusional state common in elderly patients

  • Hypoactive: lethargy, withdrawal
  • Hyperactive: agitation, hallucinations
  • Mixed

Causes

Drugs, environmental changes, constipation, infection (UTI), MI, PE

Dx: 4AT: Alertness, AMT4 (age, DOB, place, year), Attention, Acute/fluctuating course, investigations to fin underlying cause

Mx: treat underlying cause, good lighting, maintaining regular sleep-wake cycle, regular reorientation and reassurance

PO haloperidol or lorezepam for agitation if re-orientation fails

25
Q

Neuroleptic malignant syndrome

A

Rare but potentially life-threatening adverse reaction to antipsychotics

Clinical features: hyperthermia, tachy, excessive sweating, confusion, rigidity, fluctuating BP + consciousness

Ix: FBC, raised creatinine kinase

Mx: discontinue causative drug, supportive: cooling blankets and IV fluids, benzo, continuously monitoring of vitals + fluid balance

26
Q

Serotonin syndrome

A

Potentially life-threatening condition caused by excessive serotonergic activity in the CNS

Clinical features: hyperthermia, tachycardia, hypertension, excessive sweating, agitation, hyperreflexia

Mx: ABCDE, stop causative medication, anti-pyretic medications, IV fluids, benzos for agitation

27
Q

Benzodiazepines

A

MOA: potentiate GABA action (main inhibitory neurotransmitters) by being positive allostatic modulators

Lorazepam (short), diazepam (long), chlordiazepoxide

Side effects: potential for dependency

28
Q
A